Journals / Diagnostic and Interventional Radiology / 2020 / Cilt: 26 - Sayı: 6

Visual PET/CT scoring of mesenteric FDG uptake to differentiate between tuberculous peritonitis and peritoneal carcinomatosis

Pages
523–530
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

P 1 had a sensitivity (the accuracy fordiagnosis of PC) of 80.4% and a specificity (the accuracy for diagnosis of TBP) of 75.0%.CONCLUSIONA visual PET/CT scoring system based on mesenteric FDG uptake performed well in differentiating between TBP and PC.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:PURPOSEWe aimed to differentiate tuberculous peritonitis (TBP) from peritoneal carcinomatosis (PC)using a visual positron-emission tomography/computed tomography (PET/CT) scoring systembased on mesenteric fluorodeoxyglucose (FDG) uptake.METHODSPET/CT scans from 31 patients with TBP and 92 patients with PC were retrospectively reviewed.
📊
Key Findings & Data:Avisual PET/CT scoring system for mesenteric FDG uptake was used according to the following characteristics: FDG uptake intensity (low = 0, moderate = 1, high = 2), FDG uptake deposits (uniform= 0, irregular = 1, ascitic = 2), FDG uptake focality (diffuse = 0, segmental = 1, focal = 2), nodularityon the corresponding CT (nonnodular = 0, micronodular = 1, macronodular = 2) and mesenteric lymphadenopathy (absent = 0, lymphadenopathy without FDG uptake = 1, lymphadenopathywith FDG uptake = 2).
💡
Conclusion & Impact:P 1 had a sensitivity (the accuracy fordiagnosis of PC) of 80.4% and a specificity (the accuracy for diagnosis of TBP) of 75.0%.CONCLUSIONA visual PET/CT scoring system based on mesenteric FDG uptake performed well in differentiating between TBP and PC.
🔬Design:Review & Systematic Survey
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Özet

PURPOSEWe aimed to differentiate tuberculous peritonitis (TBP) from peritoneal carcinomatosis (PC)using a visual positron-emission tomography/computed tomography (PET/CT) scoring systembased on mesenteric fluorodeoxyglucose (FDG) uptake.METHODSPET/CT scans from 31 patients with TBP and 92 patients with PC were retrospectively reviewed. Avisual PET/CT scoring system for mesenteric FDG uptake was used according to the following characteristics: FDG uptake intensity (low = 0, moderate = 1, high = 2), FDG uptake deposits (uniform= 0, irregular = 1, ascitic = 2), FDG uptake focality (diffuse = 0, segmental = 1, focal = 2), nodularityon the corresponding CT (nonnodular = 0, micronodular = 1, macronodular = 2) and mesenteric lymphadenopathy (absent = 0, lymphadenopathy without FDG uptake = 1, lymphadenopathywith FDG uptake = 2). The FDG uptake intensity, deposits, focality, nodularity and mesentericlymphadenopathy scores between TBP and PC were compared using chi-square tests. The diagnostic performance of this scoring system for differentiating TBP from PC was analyzed using areceiver operating characteristic (ROC) curve. P 1 had a sensitivity (the accuracy fordiagnosis of PC) of 80.4% and a specificity (the accuracy for diagnosis of TBP) of 75.0%.CONCLUSIONA visual PET/CT scoring system based on mesenteric FDG uptake performed well in differentiating between TBP and PC.

🔖

Cite This Article

WANG, S., HE, H., XV, D., SHE, B., LU, R., YANG, Z., SHI, H., XIE, R. (2020). Visual PET/CT scoring of mesenteric FDG uptake to differentiate between tuberculous peritonitis and peritoneal carcinomatosis. Diagnostic and Interventional Radiology, Cilt: 26 - Sayı: 6, 523–530. https://ajindex.com/articles/349983

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (15)

  1. Cavalli Z, Ader F, Valour F, et al. Clinical presentation, diagnosis, and bacterial epidemiology of peritoneal tuberculosis in two university hospitals in France. Infect Dis Ther 2016
  2. 193– 199. [Crossref] 2. Guirat A, Koubaa M, Mzali R, et al. Peritoneal tuberculosis. Clin Res Hepatol Gastroenterol 2011
  3. 60–69. [Crossref] 3. Kaya M, Kaplan MA, Isikdogan A, Celik Y. Differentiation of tuberculous peritonitis from peritonitis carcinomatosa without surgical intervention. Saudi J Gastroenterol 2011
  4. 312–327. [Crossref] 4. Satoh Y, Ichikawa T, Motosugi U, et al. Diagnosis of peritoneal dissemination: comparison of 18F-FDG PET/CT, diffusion-weighted MRI, and contrast-enhanced MDCT. AJR Am J Roentgenol 2011
  5. 447–453. [Crossref] 5. Sanli Y, Turkmen C, Bakir B, et al. Diagnostic value of PET/CT is similar to that of conventional MRI and even better for detecting small peritoneal implants in patients with recurrent ovarian cancer. Nucl Med Commun 2012
  6. 509– 515. [Crossref] 6. Kyriazi S, Kaye SB, deSouza NM. Imaging ovarian cancer and peritoneal metastases--current and emerging techniques. Nat Rev Clin Oncol 2010
  7. 381–393. [Crossref] 7. Zhang M, Jiang X, Zhang M, Xu H, Zhai G, Li B. The role of 18F-FDG PET/CT in the evaluation of ascites of undetermined origin. J Nucl Med 2009
  8. 506–512. [Crossref] 8. Han N, Sun X, Qin C, et al. Value of (18)F-FDG PET/CT combined with tumor markers in the evaluation of ascites. AJR Am J Roentgenol 2018
  9. 1155–1163. [Crossref] 9. Chen R, Chen Y, Liu L, Zhou X, Liu J, Huang G. The Role of (1)(8)F-FDG PET/CT in the evaluation of peritoneal thickening of undetermined origin. Medicine (Baltimore) 2016
  10. e3023. [Crossref] 10. Sanai FM, Bzeizi KI. Systematic review: tuberculous peritonitis--presenting features, diagnostic strategies and treatment. Aliment Pharmacol Ther 2005
  11. 685–700. [Crossref] 11. Hashefi M, Curiel R. Future and upcoming non-neoplastic applications of PET/CT imaging. Ann N Y Acad Sci 2011
  12. 167–174. [Crossref] 12. Shimamoto H, Hamada K, Higuchi I, et al. Abdominal tuberculosis: peritoneal involvement shown by F-18 FDG PET. Clin Nucl Med 2007
  13. 716–718. [Crossref] 13. Wang SB, Ji YH, Wu HB, et al. PET/CT for differentiating between tuberculous peritonitis and peritoneal carcinomatosis: The parietal peritoneum. Medicine (Baltimore) 2017
  14. e5867. [Crossref] 14. Sugarbaker PH. Peritoneum as the first-line of defense in carcinomatosis. J Surg Oncol 2007
  15. 93–96. [Crossref] 15. Valle M,